These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37897191)

  • 1. Identification of apposite antagonist for androgen receptor in prostate cancer: an in silico study of fenugreek compounds.
    Olugbogi EA; Arobadade OA; Bodun DS; Omoseeye SD; Omirin ES; Fapohunda O; Ekun OE; Metibemu DS; Shodehinde SA; Saliu JA; Omotuyi OI
    J Biomol Struct Dyn; 2023 Oct; ():1-17. PubMed ID: 37897191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling, docking and dynamics studies of fenugreek (
    Kumar A; Singh VK; Kayastha AM
    J Biomol Struct Dyn; 2023 Nov; 41(19):9297-9312. PubMed ID: 36369783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational investigation of phytochemicals from
    Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
    J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Anti-Tubulin Compounds from
    Alghamdi SS; Suliman RS; Alsaeed AS; Almutairi KK; Aljammaz NA; Altolayyan A; Ali R; Alhallaj A
    Drug Des Devel Ther; 2021; 15():4195-4211. PubMed ID: 34675483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting bladder cancer with Trigonella foenum-graecum: a computational study using network pharmacology and molecular docking.
    Bitam S; Hamadache M; Hanini S
    J Biomol Struct Dyn; 2024 Apr; 42(6):3286-3293. PubMed ID: 37232424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does trigonelline help skin tone? Molecular docking studies of trigonelline on the human tyrosinase, formulation, optimization, and characterization of an emulgel-containing Trigonella foenum-graecum L. fenugreek standardized hydroalcoholic extract.
    Masjedi M; Solhjoo A
    J Cosmet Dermatol; 2022 Dec; 21(12):7178-7193. PubMed ID: 36217567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking,
    Selvaraj D; Muthu S; Kotha S; Siddamsetty RS; Andavar S; Jayaraman S
    J Biomol Struct Dyn; 2021 Feb; 39(2):621-634. PubMed ID: 31928160
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Therapeutic Ability of Fenugreek against Type 2 Diabetes and Breast Cancer Employing Molecular Docking and Molecular Dynamics Simulations.
    Rampogu S; Parameswaran S; Lemuel MR; Lee KW
    Evid Based Complement Alternat Med; 2018; 2018():1943203. PubMed ID: 30108647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Molecular Docking, Synthesis of 4-(4-benzoylaminophenoxy) Phenol Derivatives as Androgen Receptor Antagonists.
    Elancheran R; Kabilan S; Kotoky J; Ramanathan M; Bhattacharjee A
    Comb Chem High Throughput Screen; 2019; 22(5):307-316. PubMed ID: 31267866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosporone E analogues as BRD4 inhibitors for cancer treatment: molecular docking and molecular dynamic investigations.
    Makki AA; Ibraheem W; Alzain AA
    J Biomol Struct Dyn; 2023; 41(22):12643-12653. PubMed ID: 36644887
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Sheoran S; Arora S; Basu T; Negi S; Subbarao N; Kumar A; Singh H; Prabhu D; Upadhyay AK; Kumar N; Vuree S
    J Biomol Struct Dyn; 2024 Oct; 42(17):9105-9117. PubMed ID: 37615411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual targeting in prostate cancer with phytoconstituents as a potent lead: a computational approach for novel drug discovery.
    Dhawale SA; Bhosle P; Mahajan S; Patil G; Gawale S; Ghodke M; Tapadiya G; Ansari A
    J Biomol Struct Dyn; 2024 Oct; 42(17):8906-8919. PubMed ID: 37649379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA.
    Cobre AF; Maia Neto M; de Melo EB; Fachi MM; Ferreira LM; Tonin FS; Pontarolo R
    J Biomol Struct Dyn; 2024 Jul; 42(11):5881-5894. PubMed ID: 37394802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational prediction of 11β-hydroxysteroid dehydrogenase inhibitors from n-butanol fraction of
    Aribigbola TC; Omoboyowa DA; Bodun DS
    J Biomol Struct Dyn; 2023 Sep; ():1-14. PubMed ID: 37698347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of alkaloidal and glycosidal fractions from leaves of Trigonella foenum-graecum L. cv. Desi indigenous to Pakistan for antiprostaglandin evaluation as substitute of nonsteroidal anti-inflammatory drugs.
    Shaukat TM; Omer MO; Javeed A; Rehman HU; Shaukat TM
    J Ethnopharmacol; 2023 Dec; 317():116730. PubMed ID: 37336337
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Pranweerapaiboon K; Garon A; Seidel T; Janta S; Plubrukarn A; Chaithirayanon K; Langer T
    J Biomol Struct Dyn; 2022; 40(23):12674-12682. PubMed ID: 34514975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of HER2 inhibitors from curcumin derivatives using combination of
    Saibu OA; Singh G; Olugbodi SA; Oluwafemi AT; Ajayi TM; Hammed SO; Oladipo OO; Odunitan TT; Omoboyowa DA
    J Biomol Struct Dyn; 2023; 41(21):12328-12337. PubMed ID: 36752338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of HDAC8-ligands' intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents.
    Dewaker V; Srivastava AK; Arora A; Prabhakar YS
    J Biomol Struct Dyn; 2021 Aug; 39(13):4726-4751. PubMed ID: 32578494
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
    J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.